IRIS
Berti, Alvise
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.405
NA - Nord America 3.017
EU - Europa 1.871
SA - Sud America 740
AF - Africa 93
OC - Oceania 20
Totale 9.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.897
SG - Singapore 1.212
IT - Italia 761
CN - Cina 643
VN - Vietnam 599
BR - Brasile 578
RU - Federazione Russa 239
HK - Hong Kong 233
BD - Bangladesh 169
FR - Francia 141
KR - Corea 131
GB - Regno Unito 122
DE - Germania 119
LV - Lettonia 119
FI - Finlandia 108
IN - India 107
NL - Olanda 80
ID - Indonesia 77
CA - Canada 61
AR - Argentina 58
EC - Ecuador 45
JP - Giappone 37
MX - Messico 36
AT - Austria 33
ES - Italia 33
ZA - Sudafrica 26
IQ - Iraq 24
SE - Svezia 24
CO - Colombia 23
TR - Turchia 22
AU - Australia 17
MA - Marocco 17
PL - Polonia 17
UA - Ucraina 17
IR - Iran 16
SA - Arabia Saudita 16
PK - Pakistan 15
TW - Taiwan 13
EG - Egitto 12
IE - Irlanda 12
MY - Malesia 12
PH - Filippine 12
VE - Venezuela 12
CH - Svizzera 9
CL - Cile 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
PS - Palestinian Territory 8
AZ - Azerbaigian 7
DZ - Algeria 7
KE - Kenya 7
PY - Paraguay 7
JO - Giordania 6
NP - Nepal 6
UZ - Uzbekistan 6
BE - Belgio 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
LT - Lituania 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
LB - Libano 4
PE - Perù 4
CR - Costa Rica 3
LK - Sri Lanka 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AD - Andorra 2
AL - Albania 2
BB - Barbados 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CD - Congo 1
CU - Cuba 1
DJ - Gibuti 1
DK - Danimarca 1
GH - Ghana 1
GR - Grecia 1
KW - Kuwait 1
MC - Monaco 1
MK - Macedonia 1
Totale 9.139
Salva come PNG Salva come JPEG
Città #
Singapore 793
San Jose 503
Ashburn 488
Santa Clara 285
Trento 257
Dallas 235
Hong Kong 209
Columbus 188
Ho Chi Minh City 182
Hanoi 130
Moscow 126
Seoul 125
New York 119
Riga 119
Los Angeles 105
Hefei 103
Lauterbourg 100
Council Bluffs 88
Milan 87
Beijing 81
Helsinki 72
Buffalo 60
The Dalles 54
Rome 53
São Paulo 48
Redondo Beach 39
Boardman 36
Jakarta 36
Da Nang 32
Chicago 31
Rio de Janeiro 30
Orem 28
Haiphong 27
Lappeenranta 26
Tokyo 24
Washington 24
Munich 22
Nuremberg 22
Can Tho 20
Frankfurt am Main 19
London 19
Montreal 19
Chennai 18
Stockholm 18
Naples 17
Shanghai 17
Toronto 17
Quito 16
Biên Hòa 15
Bắc Ninh 15
Castello Molina di Fiemme 15
Groningen 15
Guangzhou 15
Manchester 15
Mexico City 15
Vienna 15
Warsaw 15
Miano 14
Guayaquil 13
Hyderabad 13
Hải Dương 13
Johannesburg 13
Gurugram 12
Ogden 12
Thái Bình 12
Amsterdam 11
Falkenstein 11
Kilburn 11
Paris 11
Poplar 11
Tampa 11
Turin 11
Baghdad 10
Pamplona 10
Salt Lake City 10
Turku 10
Wilmington 10
Atlanta 9
Belo Horizonte 9
Bologna 9
Brasília 9
Dublin 9
Mumbai 9
Ninh Bình 9
Porto Alegre 9
Salvador 9
Boston 8
Brooklyn 8
Cape Town 8
Istanbul 8
Phoenix 8
Ramallah 8
San Francisco 8
Baku 7
Bogotá 7
Buenos Aires 7
Cairo 7
Campinas 7
Changsha 7
Dammam 7
Totale 5.717
Salva come PNG Salva come JPEG
Nome #
Autoreactive B Cells in ANCA-Associated Vasculitis 197
Small airway dysfunction and impulse oscillometry in adult patients with asthma: recent findings 175
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow 163
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study 161
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 139
Severe asthma: One disease and multiple definitions 138
Impulse oscillometry for the evaluation and management of pediatric asthma 137
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 131
A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis 126
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 125
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells 118
Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management 117
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 113
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 109
Small airway dysfunction mediates the relationship between Fractional Exhaled Nitric Oxide and asthma control 106
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 104
Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls 104
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 100
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions 99
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 97
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 97
Interleukin-6 in ANCA-associated Vasculitis: Rationale for Successful Treatment With Tocilizumab 97
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update 97
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 97
Disease and Treatment-Related Morbidity in Young and Elderly Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis 96
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 94
Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis 94
Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes 91
Asthma and COVID-19: a dangerous liaison? 91
Oscillometry-defined small airways dysfunction as a treatable trait in asthma 91
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 90
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 90
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 89
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. 87
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series 87
Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma. 86
Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis 86
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura 85
Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease 84
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 84
Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab 84
Practical approach to vasculitides in adults: an overview of clinical conditions that can mimic vasculitides closely 84
Kaposi's Sarcoma in a Patient With Eosinophilic Granulomatosis With Polyangiitis While Taking Mycophenolate Mofetil 84
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 83
Diagnosing and treating ANCA-Associated vasculitis: An updated review for clinical practice 82
Allergic rhinitis and COVID-19: friends or foes? 81
Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study 81
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 80
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 78
Authors' response 78
Efficacy and safety of biological agents in adult-onset Still's disease 77
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 77
Remission maintenance in ANCA-associated vasculitis: does one size fit all? 76
Health Literacy and Outcomes Among Patients With Heart Failure: A Systematic Review and Meta-Analysis 76
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort 74
Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study 73
A second case of pericardial mesothelioma mimicking systemic lupus erythematosus in the literature in over 30 years: a case report 73
Small Airways: The “Silent Zone” of 2021 GINA Report? 71
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis 71
Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors of Long-term Asthma Severity 71
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 71
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 71
Erdheim-Chester disease 70
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis 69
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients 69
Severe/uncontrolled Asthma and Overall Survival in Atopic Patients With Eosinophilic Granulomatosis With Polyangiitis 69
Correction to: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan (Drugs, (2024), 84, 6, (661-684), 10.1007/s40265-024-02037-0) 69
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma 69
Tocilizumab in patients with multisystem Erdheim-Chester disease 68
Prevalence and features of IOS-defined small airway disease across asthma severities 68
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 68
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study 67
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature 67
Disease trends over time and CD4 + CCR5 + T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus 66
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. 65
Cardiovascular manifestations of Erdheim-Chester disease 64
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity 64
Chronic Rhinosinusitis in Eosinophilic Granulomatosis With Polyangiitis: Clinical Presentation and Antineutrophil Cytoplasmic Antibodies 63
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: A systematic literature review 63
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 63
Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease 62
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 61
Hypertrophic Cardiomyopathy Secondary to Hepatitis C Virus-Related Vasculitis 60
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 60
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 60
Drug induced exfoliative dermatitis: state of the art. 60
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma 59
Assessment Of Tocilizumab In The Treatment Of Cancer Cachexia 59
Small-airway dysfunction in paediatric asthma 59
BRAFV600E-mutation Is Invariably Present and Associated to Oncogene-Induced Senescence in Erdheim-Chester Disease 58
Juxta-vertebral lesions in granulomatosis with polyangiitis 57
Predicting Disease Activity in Systemic Vasculitides: On the Hunt for Potential Candidates 57
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review 56
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia 56
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media 55
Update on the epidemiology, risk factors, and outcomes of systemic vasculitides 55
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 55
Targeting the interleukin-5 pathway in EGPA: Evidence, uncertainties and opportunities 54
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis 54
Treatments for giant cell arteritis: Metaanalysis and assessment of estimates reliability using the fragility index 54
Totale 8.420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 147
Totale 41.628
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202237 0 0 0 2 9 3 2 7 2 5 3 4
2022/2023328 4 0 0 1 0 0 0 0 0 123 107 93
2023/2024322 1 1 32 13 53 83 27 12 3 27 19 51
2024/20252.850 64 22 307 499 157 303 37 97 221 298 245 600
2025/20265.990 282 201 705 1.036 570 324 1.013 145 513 460 343 398
Totale 9.527